CL2016002732A1 - Suplementación microbioma neonatal - Google Patents

Suplementación microbioma neonatal

Info

Publication number
CL2016002732A1
CL2016002732A1 CL2016002732A CL2016002732A CL2016002732A1 CL 2016002732 A1 CL2016002732 A1 CL 2016002732A1 CL 2016002732 A CL2016002732 A CL 2016002732A CL 2016002732 A CL2016002732 A CL 2016002732A CL 2016002732 A1 CL2016002732 A1 CL 2016002732A1
Authority
CL
Chile
Prior art keywords
supplementation
microbiome
neonatal
probiotic microorganism
neonatal microbiome
Prior art date
Application number
CL2016002732A
Other languages
English (en)
Spanish (es)
Inventor
Bo Möllstam
Kjersti Aagaard
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of CL2016002732A1 publication Critical patent/CL2016002732A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CL2016002732A 2014-05-20 2016-10-27 Suplementación microbioma neonatal CL2016002732A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462000842P 2014-05-20 2014-05-20

Publications (1)

Publication Number Publication Date
CL2016002732A1 true CL2016002732A1 (es) 2017-04-28

Family

ID=53284210

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016002732A CL2016002732A1 (es) 2014-05-20 2016-10-27 Suplementación microbioma neonatal

Country Status (9)

Country Link
US (1) US20170216375A1 (cg-RX-API-DMAC7.html)
EP (1) EP3145520A2 (cg-RX-API-DMAC7.html)
JP (1) JP2017515881A (cg-RX-API-DMAC7.html)
KR (1) KR20170005806A (cg-RX-API-DMAC7.html)
CN (1) CN106879253A (cg-RX-API-DMAC7.html)
AU (1) AU2015261869A1 (cg-RX-API-DMAC7.html)
CL (1) CL2016002732A1 (cg-RX-API-DMAC7.html)
MX (1) MX2016015153A (cg-RX-API-DMAC7.html)
WO (1) WO2015177246A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
AU2015340605B2 (en) 2014-10-29 2021-06-24 Biogaia Ab Use of L. reuteri for recovery of microbiota dysbiosis in early life
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
ES2928223T3 (es) * 2018-07-24 2022-11-16 Biogaia Ab Selección y uso de bacterias de apoyo a la melatonina para reducir los cólicos infantiles
CN112739814B (zh) * 2018-07-24 2023-12-08 生命大地女神有限公司 使用能够增加腺苷水平的细菌菌株的治疗方法
WO2020028871A1 (en) * 2018-08-03 2020-02-06 Research Institute At Nationwide Children's Hospital Prenatal probiotic formulations
EP3846830A4 (en) 2018-09-05 2022-07-06 Solarea Bio, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
JP7662538B2 (ja) 2019-06-03 2025-04-15 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル 敗血症および壊死性腸炎誘発神経発達不全の予防のためのプレバイオティクス製剤
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
US20250255909A1 (en) * 2022-04-14 2025-08-14 Washington University Prevotella copri formulations and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system

Also Published As

Publication number Publication date
WO2015177246A8 (en) 2016-01-14
CN106879253A (zh) 2017-06-20
US20170216375A1 (en) 2017-08-03
EP3145520A2 (en) 2017-03-29
WO2015177246A3 (en) 2016-03-03
KR20170005806A (ko) 2017-01-16
WO2015177246A2 (en) 2015-11-26
AU2015261869A1 (en) 2016-11-17
JP2017515881A (ja) 2017-06-15
MX2016015153A (es) 2017-03-07

Similar Documents

Publication Publication Date Title
CL2016002732A1 (es) Suplementación microbioma neonatal
MX2018002301A (es) Composiciones de glucano y usos de las mismas.
BR112018068126A2 (pt) sistemas e métodos para a produção e liberação de pasta fluida gelada medicinal
EA201792547A1 (ru) Популяции бактерий для стимуляции состояния здоровья
MX372771B (es) Composiciones para el cuidado bucal y métodos de uso.
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
BR112017007466A2 (pt) métodos para preparar uma composição seca e reconstituir uma composição seca, pasta, composição seca, recipiente, kit homeostático, e, seringa.
MX2017004761A (es) Uso de cannabinoides en el tratamiento de enfermedades degenerativas del musculo esqueletico.
PH12016501965A1 (en) S1p modulator immediate release dosage regimen
PH12016501087B1 (en) Lactobacillus salivarius for the treatment of mastitis
MX2019004579A (es) Composiciones para el cuidado bucal y metodos de uso.
BR112016030294A2 (pt) Cepa de bactérias probióticas de lactobacillus e uma vacina de aves domésticas, composição, ovo de aves domésticas embrionado, kit, e, método de vacinação in ovo de aves domésticas
TWD190452S (zh) 口腔保健器具
CL2016000787A1 (es) Composición farmacéutica en forma de comprimido que comprende atazanavir y cobicistat; procedimiento de preparación; y uso de la composición para preparar un medicamento útil para tratar la infección por el virus de inmunodeficiencia humana (vih).
MX2017001632A (es) Mioinositol y probioticos, y uso de estos.
GEP20196977B (en) Pharmaceutical formulations of vildagliptin
MX2019010913A (es) Analogos de deutetrabenazina, su preparacion y uso.
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
RU2014154366A (ru) Применение пробиотического штамма микроорганизма enterococcus faecium l3 для лечения нейродегенеративных заболеваний
GB2528406A (en) Prebiotic composition and method of its use
UY35631A (es) ?composición de solución de rehidratación oral que contiene probióticos?.
ECSP17023093A (es) Composiciones de ácido neridrónico o de sus productos para el tratamiento de la osteoartrosis
AR107869A1 (es) Composición para el uso en la profilaxis de la enfermedad alérgica
TWD172020S (zh) 醫療用途之燈具